| Deus Cielo, MD | |
|
55 Claverick St, Suite 100, Providence, RI 02903-4144 | |
| (401) 490-4130 | |
| (401) 455-1292 |
| Full Name | Deus Cielo |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 28 Years |
| Location | 55 Claverick St, Providence, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912957572 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MD10148 (Rhode Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rhode Island Hospital | Providence, RI | Hospital |
| Kent County Memorial Hospital | Warwick, RI | Hospital |
| The Miriam Hospital | Providence, RI | Hospital |
| Newport Hospital | Newport, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lifespan Physician Group Inc | 2567455082 | 631 |
News Archive
Onyx Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Kyprolis (carfilzomib) for Injection, a proteasome inhibitor, indicated for the treatment of patients with multiple myeloma who have received at least two prior therapies, including bortezomib and an immunomodulatory agent, and have demonstrated disease progression on or within 60 days of completion of the last therapy.
The Royal College of Occupational therapists has launched a new guide, ‘Adaptations without delay' which will help speed up the process of delivering adaptations to people's homes.
Omeros Corporation today announced the launch of its initial public offering of 6.82 million shares of its common stock. Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system.
With research increasingly showing the COVID-19 virus is transmissible via smaller droplets suspended in air, there is a growing concern current public health guidelines of mask wearing and social distancing are insufficient in combating its spread in indoor environments, like prisons, hospitals, and meatpacking plants, where people tend to be in close quarters.
The coronavirus pandemic is still rife – too many people are still becoming infected and dying every day. If the Government wants to set the country on the path to ‘normality', it must ensure that lockdown is eased safely and responsibly.
› Verified 7 days ago
| Entity Name | Lifespan Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407116643 PECOS PAC ID: 2567455082 Enrollment ID: O20121029000368 |
News Archive
Onyx Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Kyprolis (carfilzomib) for Injection, a proteasome inhibitor, indicated for the treatment of patients with multiple myeloma who have received at least two prior therapies, including bortezomib and an immunomodulatory agent, and have demonstrated disease progression on or within 60 days of completion of the last therapy.
The Royal College of Occupational therapists has launched a new guide, ‘Adaptations without delay' which will help speed up the process of delivering adaptations to people's homes.
Omeros Corporation today announced the launch of its initial public offering of 6.82 million shares of its common stock. Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system.
With research increasingly showing the COVID-19 virus is transmissible via smaller droplets suspended in air, there is a growing concern current public health guidelines of mask wearing and social distancing are insufficient in combating its spread in indoor environments, like prisons, hospitals, and meatpacking plants, where people tend to be in close quarters.
The coronavirus pandemic is still rife – too many people are still becoming infected and dying every day. If the Government wants to set the country on the path to ‘normality', it must ensure that lockdown is eased safely and responsibly.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Deus Cielo, MD Po Box 845384, Boston, MA 02284-5384 Ph: (401) 455-1749 | Deus Cielo, MD 55 Claverick St, Suite 100, Providence, RI 02903-4144 Ph: (401) 490-4130 |
News Archive
Onyx Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Kyprolis (carfilzomib) for Injection, a proteasome inhibitor, indicated for the treatment of patients with multiple myeloma who have received at least two prior therapies, including bortezomib and an immunomodulatory agent, and have demonstrated disease progression on or within 60 days of completion of the last therapy.
The Royal College of Occupational therapists has launched a new guide, ‘Adaptations without delay' which will help speed up the process of delivering adaptations to people's homes.
Omeros Corporation today announced the launch of its initial public offering of 6.82 million shares of its common stock. Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system.
With research increasingly showing the COVID-19 virus is transmissible via smaller droplets suspended in air, there is a growing concern current public health guidelines of mask wearing and social distancing are insufficient in combating its spread in indoor environments, like prisons, hospitals, and meatpacking plants, where people tend to be in close quarters.
The coronavirus pandemic is still rife – too many people are still becoming infected and dying every day. If the Government wants to set the country on the path to ‘normality', it must ensure that lockdown is eased safely and responsibly.
› Verified 7 days ago
Dr. Elias Shaaya, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-793-9135 | |
Dr. Ki-eun Chang, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy Street Apc 6, Providence, RI 02903 Phone: 401-793-9166 Fax: 401-444-2788 | |
Dr. Belinda Shao, MD, MPH Neurological Surgery Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-793-9135 Fax: 401-444-2788 | |
Dr. Petra Margarete Klinge, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 55 Claverick Street, Providence, RI 02903 Phone: 401-455-1749 Fax: 401-455-1292 | |
Sohail Syed, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Apc 6, Providence, RI 02903 Phone: 401-444-4146 Fax: 401-444-2781 | |
Albert Edward Telfeian, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Apc 6, Providence, RI 02903 Phone: 401-793-9153 Fax: 401-444-2024 | |
Dr. Beverly Claire Walters, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 128 N Main St, Providence, RI 02903 Phone: 401-351-1369 Fax: 401-251-0079 |